Vista has secured rights to the nanowire technology from Harvard and previous spinout Nanosys, which has, for the time being, eschewed biomedical applications for the tech in favor of nearer-term commercial opportunities.
The study suggests it is "unlikely" that patents protecting biomedical inventions "will ever be licensed" if they have remained unlicensed for more than eight years since their priority patent application was filed.
Already, the promise of synthetic biology is being realized as this level of engineering is brought into drug development. GT looks into synthetic biology drugs in the pipeline and where this field is heading.
According to a recent Bioinformatics paper, for each individual array, the proposed reference alignment procedure, or RAP, uses a set of selected markers as internal references to direct the signal alignment.